ChromoCure, Inc.
KKUR
Other OTC0.00
USD
- -
- -
ISIN
US1711271031
CUSIP
171127103
Return %
Stock
S&P500
1Y
- -
17.85
3Y
- -
64.56
5Y
- -
69.89
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Full Time Employees
- 4
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Address
- Reno United States of America
- IPO Date
- Apr 27, 2005
- Similar Companies
- Business
- ChromoCure, Inc. ChromoCure, Inc. (KKUR) develops and provides proprietary cancer detection systems and related therapeutic technologies to diagnostic labs. The company offers the Chromosomal Scanner Series 200 (CS200), a system that measures the unique genomic characteristic present in 100% of all cancers and absent in normal cells; it also applies its proprietary science and technology to non-toxic, non-invasive approaches for cancer therapy and cure research. ChromoCure operates in the healthcare equipment industry, focusing on oncology diagnostics and treatments for medical professionals and researchers. Founded in 2001 and headquartered at 5190 Neil Road, Suite 430, Reno, Nevada, the company was formerly known as Cyberhand Technologies International, Inc., changing its name in June 2009. No major acquisitions, partnerships, funding rounds, or new product launches have occurred in the last 1-2 years.